Skip to main content
Clinical Trials/NCT01401894
NCT01401894
Completed
Not Applicable

Pilot Study to Investigate Advanced Cancer Patient's Perspective of Their Prognosis, Goals of Treatment, and Quality of Communication With Their Oncologists

Massachusetts General Hospital1 site in 1 country50 target enrollmentStarted: October 2010Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Completion of surveys

Overview

Brief Summary

The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.

Detailed Description

  • Participants will be asked to answer a few basic questions regarding race, ethnicity, religion, relationship status, education, income, and living situation.
  • They will then be asked to complete a questionnaire which contains questions about their mood, spirituality, quality of life and their understanding of their treatment and prognosis and their communication with their oncologist. They will complete these questionnaires in the clinic or infusion room on one of their regularly scheduled visit.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Confirmed new diagnosis of advanced gastric, esophageal, pancreatic, and hepatobiliary cancer, not being treated with curative intent.
  • Planning to receive chemotherapy at Massachusetts General Hospital
  • Ability to read and respond to questions in English.

Exclusion Criteria

  • Prior chemotherapy for current stage of disease.

Outcomes

Primary Outcomes

Completion of surveys

Time Frame: 1 year

Secondary Outcomes

  • Quality of end of life care(1 year)
  • Patients perceptions of prognosis, goals of care, and communication with providers(1 year)
  • Survival(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

El-Jawahri, Areej,M.D.

Director MGH BMT Survivorship Program

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials